657 related articles for article (PubMed ID: 20399168)
1. [Hemolytic uremic syndrome in adults].
Hertig A; Ridel C; Rondeau E
Nephrol Ther; 2010 Jul; 6(4):258-71. PubMed ID: 20399168
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
3. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
4. [Hemolytic-uremic syndrome].
Bláhová K
Vnitr Lek; 2004 Jul; 50(7):519-25. PubMed ID: 15323259
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and management of thrombotic microangiopathies.
Ruggenenti P; Remuzzi G
J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
[TBL] [Abstract][Full Text] [Related]
6. [Hemolytic and uremic syndrome in the child].
Niaudet P
Nephrol Ther; 2008 Feb; 4(1):34-40. PubMed ID: 17964233
[TBL] [Abstract][Full Text] [Related]
7. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
Bertholet-Thomas A; Ranchin B; King LA; Bacchetta J; Belot A; Gillet Y; Collardeau-Frachon S; Cochat P
Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
[TBL] [Abstract][Full Text] [Related]
8. Haemolytic uraemic syndrome: an overview.
Amirlak I; Amirlak B
Nephrology (Carlton); 2006 Jun; 11(3):213-8. PubMed ID: 16756634
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue.
Atkinson JP; Liszewski MK; Richards A; Kavanagh D; Moulton EA
Ann N Y Acad Sci; 2005 Nov; 1056():144-52. PubMed ID: 16387683
[TBL] [Abstract][Full Text] [Related]
10. [Hemolytic-uremic syndrome with renal thrombotic microangiopathy].
Kanfer A
Rev Prat; 1994 May; 44(9):1205-10. PubMed ID: 7939344
[TBL] [Abstract][Full Text] [Related]
11. [Hemolytic uremic syndrome].
Rota S; Cravedi P; Remuzzi G; Ruggenenti P
G Ital Nefrol; 2005; 22 Suppl 33():S57-64. PubMed ID: 16419008
[TBL] [Abstract][Full Text] [Related]
12. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.
Dragon-Durey MA; Blanc C; Garnier A; Hofer J; Sethi SK; Zimmerhackl LB
Semin Thromb Hemost; 2010 Sep; 36(6):633-40. PubMed ID: 20865640
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in haemolytic uraemic syndrome (HUS).
Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.
Zimmerhackl LB; Besbas N; Jungraithmayr T; van de Kar N; Karch H; Karpman D; Landau D; Loirat C; Proesmans W; Prüfer F; Rizzoni G; Taylor MC;
Semin Thromb Hemost; 2006 Mar; 32(2):113-20. PubMed ID: 16575686
[TBL] [Abstract][Full Text] [Related]
16. Postpartum hemolytic uremic syndrome: a study of three cases with a review of the literature.
Segonds A; Louradour N; Suc JM; Orfila C
Clin Nephrol; 1979 Nov; 12(5):229-42. PubMed ID: 389509
[TBL] [Abstract][Full Text] [Related]
17. Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness.
Edey MM; Mead PA; Saunders RE; Strain L; Perkins SJ; Goodship TH; Kanagasundaram NS
Am J Kidney Dis; 2008 Mar; 51(3):487-90. PubMed ID: 18295065
[TBL] [Abstract][Full Text] [Related]
18. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
[TBL] [Abstract][Full Text] [Related]
19. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
[TBL] [Abstract][Full Text] [Related]
20. [Acute renal failure and thrombotic microangiopathy (TM)].
Imbasciati E; Bucci R; Barbisoni F; Borlandelli S; Corradi B; Cosci P; Farina M; Mandolfo S
G Ital Nefrol; 2003; 20(3):285-97. PubMed ID: 12881852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
